As freshly isolated CD8+ T cells could not be activated via the scBsTaFv CD8-PSCA(MB1), we finally tested whether or not pre-activated CD8+ T cells can be engaged via the co-receptor CD8 for an efficient bsAb-mediated tumor cell lysis. Here, CD8A is linked to neoplasm.